Montelukast Sodium
Product Images NDC 53808-0690

4 FDA label images from State Of Florida Doh Central Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53808-0690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 10mg (Montelukast Sod 10mg)

Label Image For 10mg (Montelukast Sod 10mg)
Packaging label for Montelukast Sodium 10 mg tablets, prescription only. The label shows a quantity of 30 tablets, lot number, expiration date, and is labeled by State of Florida DOH Central Pharmacy, Tallahassee, FL. UPC barcode present.*
FDA Label Image

Figure 1 (Montelukast Sodium 1)

Figure 1 (Montelukast Sodium 1)
A line chart showing change in height (cm) over weeks on treatment comparing three groups: SINGULAIR 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis represents weeks on treatment from -20 to 60, and the y-axis shows change in height from -2 to 7 cm. Data points indicate growth trends for each group with SINGULAIR showing a steady increase.*
FDA Label Image

Structural Formula (Montelukast Sodium 2)

Structural Formula (Montelukast Sodium 2)
Chemical structure diagram of Montelukast Sodium showing its molecular components and bonds. The structure includes aromatic rings, a sodium carboxylate group, and other distinctive features of the Montelukast Sodium molecule.*
FDA Label Image

Figure 2 (Montelukast Sodium 3)

Figure 2 (Montelukast Sodium 3)
A line graph depicting mean percent changes from baseline over weeks in treatment for two groups: Placebo and SINGULAIR. The x-axis represents weeks in treatment (0 to 15), while the y-axis shows mean percent change from baseline with numerical values. Data points include error bars indicating variability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.